Profiel
Jean Combalbert is the founder of Epics Therapeutics SA, serving as Director since 2018.
Current job includes Chairman at Syndesi Therapeutics SA. Former jobs include Chairman & Chief Executive Officer at Entomed SA from 2003 to 2009, Chief Executive Officer & Director at Ogeda SA, Non-Executive Chairman at Bioxodes SA, Director at Pharnext SA from 2020 to 2021, and Principal at Sanofi.
Education includes a doctorate from the University of Marseille.
Actieve functies van Jean Combalbert
| Bedrijven | Functie | Begin |
|---|---|---|
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Oprichter | 20-02-2018 |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Voorzitter | - |
Eerdere bekende functies van Jean Combalbert
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARNEXT SCA | Directeur/Bestuurslid | 15-07-2021 |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Voorzitter | 03-02-2009 |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Voorzitter | - |
| SANOFI | Corporate Officer/Principal | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Algemeen Directeur | - |
Opleiding van Jean Combalbert
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Health Technology |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
University of Marseille
University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Health Technology |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Health Technology |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
















